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EXPRESSION OF PROTEINS OF INTEREST IN FOOD  
1 To determine why this kind of food is created
2 To prove what are the most used techniques
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1 These products are created to satisfy the current needs of demand in their respective sectors
2 The techniques are different depending on the food which is treating (animal or vegetal)
3 There are several changes both in metabolic and physiological ambits
4 Companies have more problems than advantages in the elaboration, production and commercialization of 
this products
5 The ethical problems related to transgenic foods are so many. Some independent public doesn’t have the 
correct information about this products due to the information that national press publish to society, among 
others
3 To observe metabolic and physiological changes  
4 To examine problems and advantages associated 
with their elaboration, production or commercialization
5 To demonstrate the ethical problems that 
happens in society
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Figure 3: Human Lysozyme
(Fluorescent Green) in rice
endosperm [3]
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poder [4]
Figure 6: Physical description of the opAFP-
GHc2 AquAdvantage Construct [7]
Figure 5: Real comparison between
AquAdvantage salmon (bigger size) and
non transgenic salmon (smaller size) [5]
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Figure 8: Graphic comparison (Weight/Days) 
between Aqua salmon Advantage with non-
transgenic Atlantic salmon during the growth 
stage [5]
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Figure 7: Pronuclear microinjection.
A: Micropipette maintains the zygote
B: Fertilized pronucleus
C: Microinjection needle
D: Expansion of nuclear envelope Embryo
succesfully micro-injected [6]
